Trials / Completed
CompletedNCT00952796
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
On the basis of monotherapy for intra-abdominal infection, the investigators are conducting this study to identify the difference of drug efficacy between ampicillin/sulbactam and moxifloxacin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | moxifloxacin | moxifloxacin 400mg once daily (IV form, 60minutes) |
| DRUG | ampicillin/sulbactam | ampicillin/sulbactam 1.5g 4 times daily (IV form, administered 60minutes) |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-08-06
- Last updated
- 2011-08-02
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00952796. Inclusion in this directory is not an endorsement.